Daclatasvir and asunaprevir treatment in patients infected by genotype 1b of hepatitis C virus with no or subtle resistant associated substitutions (RAS) in NS5A‐Y93

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 90, Iss. 4, 2018-04 ,pp. : 736-744

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy Failed

By Yoshida Kanako   Hai Hoang   Tamori Akihiro   Teranishi Yuga   Kozuka Ritsuzo   Motoyama Hiroyuki   Kawamura Etsushi   Hagihara Atsushi   Uchida-Kobayashi Sawako   Morikawa Hiroyasu   Enomoto Masaru   Murakami Yoshiki   Kawada Norifumi  

International Journal of Molecular Sciences, Vol. 18, Iss. 5, 2017-05 ,pp. : 962-962

MDPI

Access to resources Recommend Favorite

Effect of Hepatitis C Virus Genotype 1b Core and NS5A Mutations on Response to Peginterferon Plus Ribavirin Combination Therapy

By Nakamoto Shingo   Imazeki Fumio   Arai Makoto   Yasui Shin   Nakamura Masato   Haga Yuki   Sasaki Reina   Kanda Tatsuo   Shirasawa Hiroshi   Yokosuka Osamu  

International Journal of Molecular Sciences, Vol. 16, Iss. 9, 2015-09 ,pp. : 21177-21190

MDPI

Access to resources Recommend Favorite

A Facile Inhibitor Screening of Hepatitis C Virus NS3 Protein Using Nanoparticle-Based RNA

By Roh Changhyun  

Biosensors, Vol. 2, Iss. 4, 2012-10 ,pp. : 427-432

MDPI

Access to resources Recommend Favorite

Physical and functional interaction between hepatitis C virus NS5A protein and ovarian tumor protein deubiquitinase 7B

By  

MICROBIOLOGY AND IMMUNOLOGY, Vol. 59, Iss. 8, 2015-08 ,pp. : 466-476

John Wiley & Sons Inc

Access to resources Recommend Favorite